Recent studies explored the use of MMP activators or small molecules to enhance ECM remodeling, demonstrating improvements in adipose tissue expandability and insulin sensitivity in animal models of obesity [45]. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.